Concepedia

Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: An EORTC Gynecological Cancer Cooperative Group study

Jan B. Vermorken, Gerardo Zanetta, C F de Oliveira, M.E.L. van der Burg, A.J. Lacave, Ivana Teodorović, G. Hoctin Boes, Nicoletta Colombo

Annals of Oncology · 2001 · 38 citations · 32 references

DOIFull text

Open access

Concepts

References

32

Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.

Philip Bonomi, John A. Blessing, Frederick B. Stehman et al. · Journal of Clinical Oncology · 1985 · 404 citations

, , +20

Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study.

G Omura, J A Blessing, Luis Vaccarello et al. · Journal of Clinical Oncology · 1997 · 273 citations

Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study.

William P. McGuire, John A. Blessing, David H. Moore et al. · Journal of Clinical Oncology · 1996 · 222 citations

Paclitaxel and Cisplatin as First-Line Therapy in Recurrent or Advanced Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

Peter G. Rose, John A. Blessing, David M. Gershenson et al. · Journal of Clinical Oncology · 1999 · 209 citations

Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix.

Claire F. Verschraegen, Tally Levy, Andrzej P. Kudelka et al. · Journal of Clinical Oncology · 1997 · 135 citations